SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-023908
Filing Date
2023-07-07
Accepted
2023-07-07 08:41:29
Documents
14
Period of Report
2023-07-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 35134
2 ex99-1.htm EX-99.1 16736
3 ex99-1_001.jpg GRAPHIC 3820
  Complete submission text file 0001493152-23-023908.txt   235870

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abeo-20230707.xsd EX-101.SCH 3045
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abeo-20230707_lab.xml EX-101.LAB 34240
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abeo-20230707_pre.xml EX-101.PRE 22379
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3307
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 231075317
SIC: 2834 Pharmaceutical Preparations